Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH DISHMAN PHARMA PANACEA BIOTECH/
DISHMAN PHARMA
 
P/E (TTM) x -60.9 30.0 - View Chart
P/BV x 0.9 3.3 26.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 PANACEA BIOTECH   DISHMAN PHARMA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
DISHMAN PHARMA
Mar-16
PANACEA BIOTECH/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs191374 51.1%   
Low Rs107129 83.1%   
Sales per share (Unadj.) Rs75.1197.0 38.1%  
Earnings per share (Unadj.) Rs-5.521.2 -26.0%  
Cash flow per share (Unadj.) Rs0.934.7 2.5%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs137.7179.9 76.6%  
Shares outstanding (eoy) m61.2580.70 75.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.3 155.6%   
Avg P/E ratio x-27.111.9 -228.1%  
P/CF ratio (eoy) x170.07.3 2,344.2%  
Price / Book Value ratio x1.11.4 77.5%  
Dividend payout %09.4 -0.0%   
Avg Mkt Cap Rs m9,14220,307 45.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2655,355 23.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59915,898 28.9%  
Other income Rs m517265 194.7%   
Total revenues Rs m5,11616,163 31.7%   
Gross profit Rs m474,103 1.1%  
Depreciation Rs m3911,091 35.9%   
Interest Rs m44944 4.7%   
Profit before tax Rs m1282,334 5.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466624 74.6%   
Profit after tax Rs m-3371,710 -19.7%  
Gross profit margin %1.025.8 4.0%  
Effective tax rate %363.526.7 1,360.4%   
Net profit margin %-7.310.8 -68.2%  
BALANCE SHEET DATA
Current assets Rs m5,62311,018 51.0%   
Current liabilities Rs m3,2979,517 34.6%   
Net working cap to sales %50.69.4 535.6%  
Current ratio x1.71.2 147.3%  
Inventory Days Days5957 103.0%  
Debtors Days Days483 1,363.5%  
Net fixed assets Rs m7,02818,787 37.4%   
Share capital Rs m61161 37.9%   
"Free" reserves Rs m8,37514,354 58.3%   
Net worth Rs m8,43614,516 58.1%   
Long term debt Rs m2024,189 4.8%   
Total assets Rs m12,71229,805 42.6%  
Interest coverage x3.93.5 112.0%   
Debt to equity ratio x00.3 8.3%  
Sales to assets ratio x0.40.5 67.8%   
Return on assets %-2.38.9 -25.9%  
Return on equity %-4.011.8 -34.0%  
Return on capital %2.017.5 11.4%  
Exports to sales %43.324.9 174.1%   
Imports to sales %24.43.7 653.5%   
Exports (fob) Rs m1,9923,956 50.4%   
Imports (cif) Rs m1,124594 189.1%   
Fx inflow Rs m1,9924,952 40.2%   
Fx outflow Rs m1,191697 170.9%   
Net fx Rs m8014,255 18.8%   
CASH FLOW
From Operations Rs m-4,2252,786 -151.6%  
From Investments Rs m4,303-1,529 -281.5%  
From Financial Activity Rs m-184-941 19.5%  
Net Cashflow Rs m-105317 -33.2%  

Share Holding

Indian Promoters % 73.6 61.4 119.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 23.0 4.1%  
FIIs % 0.3 12.0 2.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 38.6 68.4%  
Shareholders   47,091 52,291 90.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Dishman Pharma Share Price Performance

Period Panacea Biotech Dishman Pharma S&P BSE HEALTHCARE
1-Day -1.74% 2.87% 1.18%
1-Month -20.01% -2.45% -0.75%
1-Year 11.75% 96.38% 61.82%
3-Year CAGR -12.26% 89.34% 18.16%
5-Year CAGR -9.98% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.